Meta-Analysis
Copyright ©The Author(s) 2022.
World J Methodol. Sep 20, 2022; 12(5): 448-458
Published online Sep 20, 2022. doi: 10.5662/wjm.v12.i5.448
Figure 1
Figure 1 Study flow diagram.
Figure 2
Figure 2 Survival endpoints. A: 10 year disease free survival (DFS) odds ratio (OR); B: 5 year DFS OR; C: DFS hazard ratio; D: 10 year overall survival OR.
Figure 3
Figure 3 Secondary endpoints. A: Lymph node involvement; B: Extrathyroidal involvement; C: Recurrence rate; D: Recurrence microvessel density value.